HRT Financial’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-48,700
Closed -$507K 3637
2023
Q1
$507K Sell
48,700
-300
-0.6% -$3.1K 0.01% 1376
2022
Q4
$503K Hold
49,000
0.01% 1415
2022
Q3
$492K Buy
49,000
+36
+0.1% +$361 0.01% 1610
2022
Q2
$487K Sell
48,964
-36
-0.1% -$360 0.01% 1655
2022
Q1
$489K Buy
+49,000
New +$486K ﹤0.01% 1841

HRT Financial's LVAC Position: Q2 2023 in Review

HRT Financial sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 48,700 shares — an estimated $507K sold.

HRT Financial first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $507K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

  • HRT Financial reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 48,700 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $507K.
  • HRT Financial first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
  • HRT Financial's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $507K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.